BLUE bluebird bio 添加自选 4.080 -2.960-42.05% 收盘价 02/21 16:00 (美东) 3.990 -0.090-2.21% 盘后20:01 (美东) 3966.66万总市值-0.11市盈率TTM 5.650最高价4.000最低价544.27万股成交量4.900今开7.040昨收2370.10万成交额56.35%换手率亏损市盈率(静)972.22万总股本38.40052周最高-6.80市净率3940.80万流通...
BLUE bluebird bio 添加自选 8.490 +0.030+0.35% 收盘价 01/13 16:00 (美东) 8.560 +0.070+0.82% 盘前08:11 (美东) 8254.16万总市值-0.24市盈率TTM 8.705最高价8.090最低价12.18万股成交量8.250今开8.460昨收102.65万成交额1.26%换手率亏损市盈率(静)972.22万总股本38.40052周最高-14.15市净率8213.94万流通值...
BLUE | Complete bluebird bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
BLUE Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced -64.54% bluebird bio, Inc. price and volume Combination chart with 2 data series. Chart represents bluebird bio, Inc. price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart has 2 Y...
Get the latest bluebird bio Inc. (BLUE) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Bluebird bio Inc is listed as: Earnings Gainer in category See all Best Stocks lists Find stocks that match your portfolio Search stocks using popular investment metrics to help you sort through companies from all major U.S. equity markets. Use our Stock Screener Bluebird bio Inc Vitals Earnings...
Get the latest updates on bluebird bio, Inc. Common Stock (BLUE) pre market trades, share volumes, and more. Make informed investments with Nasdaq.
Latest bluebird bio Inc (BLE0:BER) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
News See more Yahoo Finance • last year 12 Most Promising Gene Editing Stocks According to Hedge Funds Yahoo Finance • last year Down 30% in a Week, What in the World Is Going On With Bluebird Bio Stock? Yahoo Finance • last year bluebird bio Details Plans for the Commer...
富国银行:维持bluebird bio(BLUE.US)评级,由持股观望调整至持股观望评级, 目标价由40.00美元调整至5.00美元。 bluebird bio(BLUE.US)公司简介:Bluebird Bio Inc是一家生物技术公司,基于其专有的慢病毒载体( LVV )基因添加平台,致力于研究、开发和商业化针对严重遗传病的潜在治愈基因疗法。 该公司在单一部门运营,专...